GLYYY yields 1.43% · PFE yields 6.13%● Live data
📍 GLYYY pulled ahead of the other in Year 1
Combined, GLYYY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GLYYY + PFE for your $10,000?
Glory Ltd. develops and manufactures cash handling machines and systems. It operates through Financial Market, Retail and Transportation Market, Amusement Market, and Overseas Market segments. The company provides teller cash recyclers, bank note counters, bank sorters, coin dispensers, coin sorters, coin counters, coin wrappers, and rolled coin dispensers, as well as self service solutions, bank note deposit solutions, and assisted service software solutions; cash recycling systems, front office-cash recyclers, banknote recyclers, payment station, and coin deposit solutions; remote customer displays; UW-F series; WR-90/500; and OEM cash dispensing systems, OEM cash deposit machines, and OEM cash recycling systems. The company also offers software solutions, such as business intelligence, device management, resource planning, retail cash management, serial number management, teller connectivity, and managed services. In addition, it offers professional, maintenance, and Ubiqular manage treasury managed services. Further, the company offers open teller systems, card systems, pachinko prize dispensing machines, and ticket vending machines, as well as self-service kiosks, mail ordering systems, and digital menu boards. It serves the CIT, financial, gaming, OEM, restaurant, amusement, and retail industries. The company was formerly known as Kokuei Machinery Manufacturing Co., Ltd. and changed its name to Glory Ltd. in 1971. The company was founded in 1918 and is headquartered in Himeji, Japan.
Full GLYYY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.